Browsing Tag
orphan medicines
1 post
Why Avanzanite’s hire of Dr. Mark Bechter could reshape how orphan drugs reach patients across 32 countries
Avanzanite Bioscience hires Dr. Mark Bechter as SVP medical affairs to drive rare disease growth, with H1 2025 revenues tripling. Learn more.